source
- Experts call for licensing framework as Utah pauses AI chatbot prescription programAlon Bergman, an assistant professor of medical ethics at the University of Pennsylvania, argues that AI-driven medical tools need a licensing system. He points to Utah’s recent pilot with the AI c…
- Medicare cuts projected spending on new Alzheimer’s drugs as uptake remains lowMedicare is spending far less on the recently approved Alzheimer’s treatments Leqembi and Kisunla than officials had anticipated. The Centers for Medicare and Medicaid Services said the agency does…